Friday, 25 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 4, 2026

Medallion Financial Corp. Exposes ZimCal’s Latest Campaign of Distortion and the Risks of Electing Its Unqualified Nominees

View original at globenewswire.com
Medallion Financial Corp…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Medallion's total shareholder return is the lowest in its peer group

    60% confidence
  • Q1 results reflect strong loan growth requiring upfront CECL reserves (the 'growth penalty'); net income over five years totals $266 million, book value per share rose 53% since 2021, and net interest income grew at a 14.1% CAGR since 2021

    60% confidence
  • The Board of Directors unanimously concluded that the ZimCal nominees are materially unqualified to serve on the board of a regulated consumer lending institution and their election would introduce regulatory risk and operational disruption

    60% confidence
  • The SBA matter was a technical issue related to SBA rules and not a financial default; it did not arise from criticism of credit performance or concerns about meeting financial obligations, and the Company has received positive SBA feedback on the cure

    60% confidence
  • Medallion's performance has been declining

    60% confidence
  • Medallion's total shareholder return since the transformation is 452% and has outperformed its peer group over 1-, 3-, and 5-year periods based on the true unaffected date; Hodges extends the measurement period to May 1, 2026 to manufacture a negative comparison

    60% confidence
  • One former employee's four-year-old lawsuit against several defendants that has not proceeded beyond the pleadings stage is hardly material information

    60% confidence
  • The Board has not held management accountable, citing director ages and tenure

    60% confidence
  • ZimCal's goal across three consecutive proxy contests is a debt buyout at above-market price with misaligned incentives, and its campaign contains distortions about key issues

    60% confidence
  • Eric Kelly diverted customer revenue for personal benefit, misappropriated over 10% of customer prepayments, committed tax fraud by misrepresenting inventory risk, and terminated the CFO within two hours of a whistleblower complaint

    60% confidence
  • Medallion invested enormous time in dozens of meetings and correspondence with Hodges and always engaged in good faith; in late 2023 the Company offered to purchase his trust preferred securities at a fair price, which he rejected, demanding a premium

    60% confidence
  • ZimCal has engaged with Medallion over 50 times and been ignored or dismissed nearly every time

    60% confidence
  • The Company would face a proxy contest 'every year' if it refused to buy out his debt on his terms

    60% confidence
  • Medallion has demonstrated consistent execution across the company's business lines

    60% confidence
  • Kelly allegedly asserted sole authority over the company's numbers regardless of accounting objections

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI Agents Scale Up Through Partnerships and Funding, But Data Readiness Lags Ambition
A wave of vertical AI-agent startups (Swarm, Veridox, Avallon AI, DA2, F2, Earthian, Meanwhile, Covecta, Penguin AI, Maisa AI) is being funded and profiled just as major infrastructure players — Microsoft/Mistral, Siemens/NVIDIA, and Manulife/Microsoft — cement enterprise AI governance and compute partnerships. Yet a Google Cloud report shows AI agents still lack access to the majority of company data (only 45% on average), and insider selling at incumbent C3.ai signals investor caution even as adoption intent (100% planned agentic AI use within two years) races ahead of actual data infrastructure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,984
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,984 facts checked against source5,306 source documents archived
Query this data → isubstrate.com